- Home
- A-Z Publications
- Current Drug Safety
- Previous Issues
- Volume 12, Issue 1, 2017
Current Drug Safety - Volume 12, Issue 1, 2017
Volume 12, Issue 1, 2017
-
-
Nifedipine Induced Gingival Hyperplasia in Pregnancy: A Case Report
Authors: Brochet M.S., Harry M. and Morin F.Background: It is known that calcium channel blockers are associated with a risk of gingival hyperplasia. These drugs are widely used in the management of gestational hypertensive disorders. Case: A 27-year-old G1 woman presented with gingival hyperplasia at 27 weeks gestation during a hospitalisation for preeclampsia. She had been on nifedipine for hypertension for the last 9 weeks. Nifedipine was discontinued Read More
-
-
-
Severe Coagulation Disorder and Thrombocytopenia Associated with Tigecycline - Case Report and Review of Literature
Authors: Sami Giryes, Zaher S. Azzam, Reem Ismael-Badarneh, Norberto Krivoy and Gidon BergerHerein, we report a 70-year-old male patient, with recurrent multiple hepatic abscesses, that was admitted to the internal medicine department for treatment of Carbapenem Resistant Escherichia Coli (CRE) bacteremia. The patient was treated with Tigecycline; few days later, he developed "Disseminated Intravascular Coagulation (DIC)" like coagulation study abnormality that seemed to be related to Tigecycline treatment. U Read More
-
-
-
Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin
The fixed dose combination of sitagliptin 50 mg and metformin 850 mg (Janumet ®), is indicated for the treatment of type 2 diabetes mellitus in addition to diet and exercise to improve glycemic control in patients treated with metformin alone. Methods: We report a 69-year-old man with type 2 diabetes that developed sudden loss of eyebrows and eyelashes about 4 months after the beginning of Janumet®. Clinical and laborat Read More
-
-
-
Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency
Authors: Maliha Khan, Shilpa Paul, Saad Farooq, Thein H. Oo, Priya Ramshesh and Nitin JainBackground: Rasburicase is commonly used in patients with hematologic malignancies for tumor lysis syndrome prophylaxis and management. Methemoglobinemia is a serious rare adverse effect of rasburicase, more common in patients with G6PD deficiency. Prompt diagnosis and appropriate management of this condition can make the difference between successful recovery and significant morbidity. Here we disc Read More
-
-
-
Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review
Authors: Subramoniam Madhusoodanan, Leah R. Steinberg, Alisa Coleman and Samuel BavliBackground: Hyperprolactinemia can be caused by medications, primarily antipsychotics, or by anterior pituitary tumors. The consequences of hyperprolactinemia including gynecomastia, galactorrhea, and sexual dysfunction are very disturbing for males and females. It is sometimes difficult to differentiate the etiology of hyperprolactinemia from a clinical perspective. Objective: Identification of the etiology of hyperpr Read More
-
-
-
Prescription Opioid Abuse and its Potential Role in Gross Dental Decay
Authors: Andrew D. Fraser, Boshi Zhang, Hassan Khan, Henry Ma and Elliot V. HershIntroduction: Prescription opioid abuse may have adverse dental effects that are irreversible, leaving younger populations with substantially decayed dentitions. This article explores the damaging effects of three years of prescription opioid abuse to a twenty-six-year-old’s dentition and oral health. Case Presentation: A twenty-six-year-old Caucasian male presented to the University of Pennsylvania School of Dental Medic Read More
-
-
-
Safety of Technosphere Inhaled Insulin
More LessBackground: Technoshere insulin (TI), Afrezza, is a form of short-acting human insulin taken by oral inhalation with meals. Methods: literature search (English, French, Spanish) of all human studies and pertinent animal and in-vitro studies related to technosphere insulin until September 2016 with special emphasis on its safety. Results: Compared to subcutaneous insulin aspart, TI is slightly less effective, the difference in Read More
-
-
-
Examination of QTc Values in Critically Ill Patients Diagnosed with Delirium and Prescribed Atypical Antipsychotics
Authors: Nicole Palazzolo, Bridgette Kram and Andrew J. MuzykObjective: To determine the extent of QTc prolongation following administration of an atypical antipsychotic in critically ill patients diagnosed with delirium and to conduct an assessment of risk factors to identify the presence of specific risk factors associated with QTc prolongation in this patient population. Methods: Patients were included if they were at least 18 years of age, admitted to an Intensive Care Unit (ICU) at the Read More
-
-
-
Fatal Intoxications in the North of Portugal: 12 Years of Retrospective Analysis
Background: Fatal intoxications are a topic of great relevance in today’s society. They typically occur by accidental or voluntary ingestion, but its characterization by a forensic perspective was not fully explored. Objective: This study retrospectively reviews fatal intoxication cases autopsied at the northern forensic medicine services of Portugal, between 2001 and 2013. Method: For this purpose, we analyzed postmortem forens Read More
-
-
-
A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending a Tertiary Care Hospital
Authors: Khyati Doshi, Radha Yegnanarayan and Neeta GokhaleObjectives: Find possible causative agents causing cutaneous adverse reactions; clinical patterns, causality and severity of Drug induced cutaneous adverse reactions (CADR) and treatment outcome. Methods: Retrospective study was undertaken including cases of CADR. Causality, preventability and severity of Drug Induced cutaneous reactions were judged with the use of Naranjo's algorithm, WHO causality scale, modified Schu Read More
-
-
-
An Evaluation of Indian Consumers’ Reporting of Suspected Adverse Drug Reactions with a Designated Reporting Form
Authors: Harmeet Singh Rehan, Ravinder Sah, Anubhuti Gupta and Parvesh NagarAbstract: Background: The Pharmacovigilance Program of India recently initiated a process for direct patient reporting of Adverse Drug Reactions (ADRs) with a designated form. Patients and Methods: A survey of 200 patients reporting ADRs filling the form. Forms were analysed for patient data, the suspected medication(s), ADRs and possible causality. Results: 54.3% of respondents provided their contact information; the im Read More
-
-
-
Dispensing Patterns of Anxiolytics and Sedative-Hypnotics: A Feasibility Study Comparing Datasets from a Developed and a Developing Country (Australia and South Africa)
Authors: Therese Kairuz, Ilse Truter, Laurence Rossato and Alex PudmenzkyBackground: Dispensing patterns reflect drug usage trends. Benzodiazepines are known as drugs with potential for misuse, and frequent dispensing may be a surrogate marker of misuse. Objective: The primary aim of this study was to obtain a comparative snapshot of anxiolytic and sedative-hypnotic dispensing in a developing country and a developed country, to determine whether further research about benzodiazepines is Read More
-
-
-
Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials
Authors: Chadwick K. Mellen, Jennifer E. Ryba and Joseph P. RindoneBackground: Observational studies have suggested an increased risk of nephrotoxicity when piperacillin-tazobactam is added to vancomycin, although the data are confliciting. Objective: To perform a meta-analysis of identified studies to assess if adding piperacillin-tazobactam to vancomycin increases the incidence of nephrotoxicity. Method: A systematic review of PubMed, EMBASE, Cochrane Central, and Google Read More
-
-
-
Safety Considerations in the Use of Ketorolac for Postoperative Pain
Authors: Benjamin Maslin, Lawrence Lipana, Brandon Roth, Gopal Kodumudi and Nalini VadiveluBackground: Ketorolac use has significantly expanded for postoperative pain management since it first became available in the United States, primarily due to well established effects on patient pain scores and its ability to reduce perioperative opioid requirements. As an inhibitor of cyclooxygenase, ketorolac use has raised clinical concern including particular controversy regarding its potential effects on bone healing Read More
-
Volumes & issues
-
Volume 20 (2025)
-
Volume 19 (2024)
-
Volume 18 (2023)
-
Volume 17 (2022)
-
Volume 16 (2021)
-
Volume 15 (2020)
-
Volume 14 (2019)
-
Volume 13 (2018)
-
Volume 12 (2017)
-
Volume 11 (2016)
-
Volume 10 (2015)
-
Volume 9 (2014)
-
Volume 8 (2013)
-
Volume 7 (2012)
-
Volume 6 (2011)
-
Volume 5 (2010)
-
Volume 4 (2009)
-
Volume 3 (2008)
-
Volume 2 (2007)
-
Volume 1 (2006)
Most Read This Month
Article
content/journals/cds
Journal
10
5
false
en
